Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pain relief of methoxyflurane in patients with burns
2020-005865-14Phase 4Terminated
- Sponsor
- Rigshospitalet
- Start
- Dec 2020
- Modality
- Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of methoxyflurane in burn injury, sponsored by Rigshospitalet. Primary endpoint: Pain intensity. Started Dec 2020; status: terminated.
02
Drugs
methoxyflurane
03
Conditions
burn injury
Beyond the preview
Go deeper on 2020-005865-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-005865-14.